Hereditary hemorrhagic telangiectasia (HHT) and cardiovascular risk: Is HHT cardioprotective?

被引：0
|
作者：
Power, S. P. [1 ]
Kilian, A. [2 ,3 ]
Prabhudesai, V [1 ,2 ,3 ]
Lee, W. L. [4 ]
Marcuzzi, D. [1 ]
Faughnan, M. E. [2 ,3 ,4 ]
机构：
[1] St Michaels Hosp, Dept Vasc & Intervent Radiol, Toronto, ON, Canada
[2] St Michaels Hosp, Toronto HHT Ctr, Toronto, ON, Canada
[3] Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[4] Univ Toronto, Div Respirol, Dept Med, Toronto, ON, Canada
来源：
ANGIOGENESIS | 2019年 / 22卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [1] Congenital asplenia and hereditary hemorrhagic telangiectasia (HHT).
    Vedere, T
    Kumar, P
    Sorensen, R
    Hudson, J
    Kamboj, S
    Thompson, J
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 51A - 51A
  • [2] Liver involvement in hereditary hemorrhagic telangiectasia (HHT)
    Garcia-Tsao, Guadalupe
    JOURNAL OF HEPATOLOGY, 2007, 46 (03) : 499 - 507
  • [3] Outcomes of Liver Transplantation for Hereditary Hemorrhagic Telangiectasia (HHT)
    Saberi, B.
    Heimbach, J.
    Larson, J.
    Raghavaiah, S.
    Krowka, M.
    Kamath, P.
    Leise, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 750 - 751
  • [4] Outcomes of Liver Transplantation for Hereditary Hemorrhagic Telangiectasia (HHT)
    Saberi, B.
    Heimbach, J.
    Larson, J.
    Raghavaiah, S.
    Krowka, M.
    Kamath, P.
    Leise, M.
    TRANSPLANTATION, 2014, 98 : 750 - 751
  • [5] Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management
    Hammill, Adrienne M.
    Wusik, Katie
    Kasthuri, Raj S.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 469 - 477
  • [6] Population with hereditary hemorrhagic telangiectasia of the Winnipeg HHT Clinic
    Hoogervorst, Britta
    De Gussem, Els
    ANGIOGENESIS, 2015, 18 (04) : 568 - 568
  • [7] Investigation of the genetic mechanism of telangiectasia formation in hereditary hemorrhagic telangiectasia (HHT)
    Wooderchak-Donahue, W.
    Tarapcsak, S.
    Mcrae, B.
    Oakley, G.
    McDonald, J.
    Szankasi, P.
    Henslee, S.
    Bolia, A.
    Marth, G.
    Putnam, A.
    Whitehead, K.
    Bayrak-Toydemir, P.
    ANGIOGENESIS, 2023, 26 (01) : S18 - S18
  • [8] Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence
    de Gussem, Els M.
    Kroon, Steven
    Hosman, Anna E.
    Kelder, Johannes C.
    Post, Martijn C.
    Snijder, Repke J.
    Mager, Johannes J.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11
  • [9] Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT)
    Chavan, Ajay
    Schumann-Binarsch, Silke
    Luthe, Lars
    Nickau, Britta
    Elsaesser, Albrecht
    Kuehnel, Thomas
    Geisthoff, Urban
    Koehne, Henning
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2013, 42 (02) : 106 - 110
  • [10] Doxycycline for the treatment of hereditary hemorrhagic telangiectasia (HHT)-related epistaxis
    Kukkadapu, T.
    Whitehouse, A.
    Sims, J.
    Gossage, J.
    ANGIOGENESIS, 2019, 22 (04) : 628 - 629
12345